Article
Pan-cancer analysis to provide a reliable basis for the clinical use of TIM-3 immunosuppressants
2023-01-11
Abstract excerpt
<h4>Background: </h4> TIM-3 belongs to the immunoglobulin superfamily and is currently one of the most valuable immunosuppressants. HAVCR2 is the gene that codes for TIM-3, and its expression has been linked to the clinical efficacy of TIM-3 immunosuppressants. The study aims to provide potential guidance for the use of TIM-3 immunosuppressants in pan-cancer. Methods Data related to HAVCR2 in pan-cancer was obtai...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 73207612-d14a-59bf-a96d-57d9e7c37096
- DOI
- 10.21203/rs.3.rs-2446588/v1
